These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 21138634

  • 1. [The short-term efficacy of nucleoside analogue on the treatment of acute-on-chronic liver failure].
    Liu XY, Wang HF, Hu JH, He WP, Wang HQ, Liu N.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):845-8. PubMed ID: 21138634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Sun LJ, Yu JW, Zhao YH, Kang P, Li SC.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744
    [Abstract] [Full Text] [Related]

  • 4. [Discussion on the meaning of MELD score in the opportunity of the entecavir treatment of HBeAg-negative acute-on-chronic liver failure].
    Yan Y, Mai L, Zhu JY, Zhang Y, Ke WM.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):466-9. PubMed ID: 22734238
    [Abstract] [Full Text] [Related]

  • 5. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J, Han JH, Liu C, Yu RH, Li FZ, Li QF, Gong GZ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [Abstract] [Full Text] [Related]

  • 6. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
    Yu JW, Sun LJ, Zhao YH, Li SC.
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
    Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F, Emtricitabine FTCB-301 Study Group.
    Arch Intern Med; 2006 Jan 09; 166(1):49-56. PubMed ID: 16401810
    [Abstract] [Full Text] [Related]

  • 9. [The short-term efficacy of antiviral treatment in patients with acute-on-chronic hepatitis B liver failure].
    Xu QH, Chen LB, Xu Z, Shu X, Chen N, Cao H, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec 09; 23(6):467-9. PubMed ID: 20718359
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of lamivudine on acute-on-chronic liver failure in patients with chronic hepatitis B].
    Xiao L, Qi JH, Shi XF, Sun YC, Yan XZ, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun 09; 20(6):438-41. PubMed ID: 23044201
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks].
    He H, Xu ZN, Cai DC, Nai N, Ling N, Zeng WQ, Shi XF, Zhao YR, Zhou Z, Zhang DZ.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 09; 17(4):271-4. PubMed ID: 19403025
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 09; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Expression of COX-2 and PPARg in the livers of patients with acute on chronic HBV-related liver failure and their relationship with clinic parameters].
    Niu YH, Yi RT, Liu HL, Chen TY, Zhang SL, Zhao YR.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul 09; 19(7):511-6. PubMed ID: 22152242
    [Abstract] [Full Text] [Related]

  • 15. [Case-controlled study of entecavir treatment for chronic severe hepatitis B].
    Xiao GM, He KY, Jia WD, Lei CL, Yang Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb 09; 23(1):56-8. PubMed ID: 19799020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.
    Hepatobiliary Pancreat Dis Int; 2004 May 09; 3(2):188-93. PubMed ID: 15138107
    [Abstract] [Full Text] [Related]

  • 18. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
    Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, Colonno R, Fernandes L, BEHoLD AI463027 Study Group.
    N Engl J Med; 2006 Mar 09; 354(10):1011-20. PubMed ID: 16525138
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure].
    He WP, Hu JH, Tong JJ, Liu FF, Wang HF.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1173-7. PubMed ID: 21756769
    [Abstract] [Full Text] [Related]

  • 20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May 10; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.